EMCDDA. New drugs in Europe, 2014, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2015. 879 kB.
Montenarh, D; Hopf, M; Warth, S; Maurer, HH; Schmidt, P; Ewald, AH. A simple extraction and LC-MS/MS approach for the screening and identification of over 100 analytes in eight different matrices: Detection of 130 analytes in eight biosamples using only one LC-MS/MS method. Drug Test. Anal., 1 Mar 2015, 7 (3), 214-240. 593 kB. https://doi.org/10.1002/dta.1657
Currie, KS. Antianxiety Agents. In Burger's Medicinal Chemistry and Drug Discovery; Abraham, DJ, Ed., John Wiley & Sons, Inc., 15 Jan 2003; pp 525–597. 2.7 MB. https://doi.org/10.1002/0471266949.bmc102 #5,42
Chambers, SA; DeSousa, JM; Huseman, ED; Townsend, SD. The DARK side of total synthesis: Strategies and tactics in psychoactive drug production. ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2307–2330. 8.1 MB. https://doi.org/10.1021/acschemneuro.7b00528 #103
Ntoupa, PA; Papoutsis, II; Dona, AA; Spiliopoulou, CA; Athanaselis, SA. A fluorine turns a medicinal benzodiazepine into NPS: The case of flualprazolam. Forensic Toxicol., 1 Jul 2021, 39 (2), 368-376. 795 kB. https://doi.org/10.1007/s11419-020-00565-4 #Alprazolam
Clayton, T. Part I. Unified pharmacophore protein models of the benzodiazepine receptor subtypes. Part II. Subtype selective ligands for α5 GABA(A)/BZ receptors. Ph. D. Thesis, University of Wisconsin-Milwaukee, 1 Dec 2012. 28.1 MB. #Alprazolam